Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, raised $78 million by offering 4.6 million shares (up from 4.4 million) at $17, the high end of the range of $15 to $17. Entellus Medical plans to list on the NASDAQ...read more
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more
Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, announced terms for its IPO on Thursday. The Plymouth, MN-based company plans to raise $70 million by offering 4.4 million shares at a price range of $15 to $17. At...read more
US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs
Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more
Entellus Medical prices upsized IPO at $17, the high end of the range
Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, raised $78 million by offering 4.6 million shares (up from 4.4 million) at $17, the high end of the range of $15 to $17. Entellus Medical plans to list on the NASDAQ...read more
Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care
Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more
Sinus balloons for sale: Entellus Medical sets terms for $70 million IPO
Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, announced terms for its IPO on Thursday. The Plymouth, MN-based company plans to raise $70 million by offering 4.4 million shares at a price range of $15 to $17. At...read more